Tuesday, March 17, 2020

Word War

By following China Daily one can get a glimpse as to the battle brewing.

Today they announced:

It is the foppery of hardliners in the US administration that, perceiving the US to be sick in fortune, they seek to make China guilty of being the cause of all the country's ailments. Having reexamined the US' engagement with China over the past more than 40 years, these ideological blowhards have concluded that China is not behaving to their liking and so have sought to exert comprehensive pressure on China in order to persuade it to change its ways. Now, as part of this campaign, the screws are being tightened on Chinese media organizations in the US. The five Chinese organizations that have fallen foul of the rivalry these ideologues imagine with China strictly abide by US laws and serve to promote greater understanding between the two peoples. However, the Cold War mentality that at present prevails in Washington means the administration now has these organizations in its sights. As such, China's counter-measures are fully justified. Although it does not seek to escalate the media war, Beijing has consistently made it clear it will act reciprocally in response to any pressure moves by Washington. But both sides should bear in mind that media organizations from the two countries have played indispensable roles in deepening Sino-US interactions over the past four decades by strengthening mutual understanding and trust between the two countries, which established their diplomatic relations at a time of great division in the world. Despite the ups and downs in bilateral political ties, economic and trade cooperation has thrived and human and cultural exchanges have continually expanded over the years since then, proving that the two sides can get along if they accommodate their differences.

Perhaps we should get our therapeutics out of there as well as many of the other things we now rely upon.

Yield Curve

Thought we would digress. This is the yield curve and we seem to be approaching free money!

On the one hand, then on the other...

The NY Times reports on a Brit analysis of the impact of the Wuhan Virus. We have been doing a similar analysis as noted herein and the issue in the US is a bit different. Take West Virginia. Still as of last night uninfected. The issue is population density and migration of the virus. Frankly it is surprising but some folks are talking of building a wall on the Potomac and Shenandoah and the Ohio rivers to keep folks from coming into the state. I think it is morgue humor but I leave that to others.

The Brit study may clearly apply to London, Manchester etc and also New York and other major US cities. There are sections of the US where we still have significant separation and low rates of entry. The July/August dates also I believe assume slow mitigation. This changes dramatically with drastic mitigation. Namely, May/June if what is now happening is sustained.

There is always the what-if issues at hand. Fear and panic can be worse than the disease itself. Go 15 miles from New York City and individual separation increases, if an only if people follow guidelines.

Now back to the NY Times piece. One would assume that responsible reporting would include a broader analysis of the issue. Unfortunately the press in my opinion is making much of this worse. But we shall see.

Happy Saint Patrick's Day

As the good saint chased the snakes out of Ireland perhaps he can help with the Wuhan Flu! Suggestion of the day: Pray!

Monday, March 16, 2020

Pharma Supply Chain

As we have noted multiple times before the reliance on China as a key element in our pharma supply chain is an exceptionally high risk factor. As JAMA has just noted:

As the US and other countries have increasingly become dependent on procuring the ingredients for many pharmaceutical agents from India or China, oversight by the US Food and Drug Administration (FDA) of non-US manufacturers has not kept pace. In 2018, the FDA conducted onsite inspections of only about 20% (935) of the estimated more than 4000 registered non–US human drug manufacturing facilities abroad, and language barriers, travel constraints, and bureaucratic issues have created challenges with completing the inspections. In congressional testimony in 2019, the FDA has cited inspector vacancies, lengthy training requirements, and restrictive foreign facility policies as impediments to a more rapid ramp-up of its overseas inspections.7 The FDA has issued multiple recalls of suspected contaminated drugs in recent years, including the widely reported alert involving much of the generic drug valsartan, which was found to contain the carcinogenic contaminant, N-nitrosodimethylamine. In 2008, a recall of contaminated heparin containing components traced to unregulated Chinese family pig farms was associated with 81 deaths in the US. Both the valsartan and heparin recalls involved contamination from Chinese factories that lacked adequate inspections by US regulators.

 Hopefully the current viral outbreak will open the eyes of regulators and lawmakers to the irreparable harm that could result if we allow this to continue!

Interesting Paper from Wuhan

In July 2016 the  Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China published a paper discussing the work they did in modifying a SARS like corona virus. The paper appears on Semantic Scholar.

The authors state:

 Bats harbor severe acute respiratory syndrome (SARS)-like coronaviruses (SL-CoVs) from which the causative agent of the 2002-2003 SARS pandemic is thought to have originated. However, despite the fact that a large number of genetically diverse SL-CoV sequences have been detected in bats, only two strains (named WIV1 and WIV16) have been successfully cultured in vitro. These two strains differ from SARS-CoV only in containing an extra open reading frame (ORF) (named ORFX), between ORF6 and ORF7, which has no homology to any known protein sequences. In this study, we constructed a full-length cDNA clone of SL-CoV WIV1 (rWIV1), an ORFX deletion mutant (rWIV1-X), and a green fluorescent protein (GFP)-expressing mutant (rWIV1-GFP-X). Northern blotting and fluorescence microscopy indicate that ORFX was expressed during WIV1 infection. A virus infection assay showed that rWIV1-X replicated as efficiently as rWIV1 in Vero E6, Calu-3, and HeLa-hACE2 cells. Further study showed that ORFX could inhibit interferon production and activate NF- B. Our results demonstrate for the first time that the unique ORFX in the WIV1 strain is a functional gene involving modulation of the host immune response but is not essential for in vitro viral replication. 

 One should read through this carefully and cautiously. The mapping of the bases of this virus map well onto what is currently spreading worldwide. There is no claim other than that of coincidence. The paper is worth the read. I want to thank colleagues in California for the reference.